Sign in

    Stephen L. Silvestro

    Chief Executive Officer at OptimizeRx
    Board
    Since March 10, 2025
    Age
    47 years
    Education
    Holds a Master of Liberal Arts in Business Management from Harvard University and a Bachelor of Arts in Italian and Business Management from Brigham Young University.
    Tenure
    Joined OPRX on April 29, 2019 as Chief Commercial Officer, promoted to President in October 2023, served as Interim CEO in January 2025, and started his current role as CEO on March 10, 2025.

    Also at OptimizeRx

    DB
    Doug Besch
    Chief Product Officer and Chief Technology Officer
    ES
    Edward Stelmakh
    Chief Financial Officer (CFO) and Chief Operations Officer (COO)
    MO
    Marion Odence-Ford
    Chief Legal Officer and Chief Human Resources Officer

    About

    Stephen L. Silvestro is the Chief Executive Officer of OptimizeRx Corporation and is 47 years old as of March 20, 2025. He has a strong academic background, holding a Master of Liberal Arts in Business Management from Harvard University and a Bachelor of Arts in Italian and Business Management from Brigham Young University.

    Before joining OptimizeRx, he built an impressive career with roles at CCH® Tagetik, Prognos Health, Inc., and Decision Resources Group, where he advanced his expertise in global sales and commercial operations.

    At OptimizeRx, he began his tenure as Chief Commercial Officer on April 29, 2019, was later promoted to President in October 2023, and then served as Interim CEO in January 2025, before officially assuming the role of CEO on March 10, 2025.

    His career reflects a dedication to strategic leadership and operational excellence, making significant contributions to the company’s evolution and long-term growth.

    $OPRX Performance Under Stephen L. Silvestro

    Past Roles

    OrganizationRoleDate RangeDetails
    OPRX Interim Chief Executive Officer January 1, 2025 - March 10, 2025 Served as interim until permanent appointment
    OPRX President October 2023 - January 1, 2025 Served until promotion
    OPRX Chief Commercial Officer April 2019 - October 2023 Held the role until further advancement within the company
    CCH® Tagetik (Wolters Kluwer) Vice President and General Manager January 2018 - April 2019 Led corporate performance management solutions
    Prognos Health, Inc. Chief Commercial Officer April 2017 - January 2018 Held a leadership position in healthcare data and analytics
    Decision Resources Group Executive Vice President, Head of Global Sales September 2007 - April 2017 Last served in this role before transitioning to other opportunities

    Fixed Compensation

    Data from  FY 2024
    Component NameAmountPayment ScheduleAdditional Details
    Salary$400,000Semi-monthly at $16,666.66 per pay periodBase salary for 2024
    Stock Awards$228,173 (grant date fair value)RSU grants on Feb 15, 2024 (7,750 RSUs) and Dec 23, 2024 (41,408 RSUs)Granted as part of bonus compensation
    Option Awards$199,999 (grant date fair value)Granted on Dec 23, 2024 (77,742 stock options)Awarded to recognize performance
    Technology Reimbursement$3,600As incurredProvided for technology expenses

    Performance Compensation

    Data from  FY 2024

    Non-Equity Incentive Plan Compensation

    • Performance Metrics:
      • Revenue: 50% weighting
      • Adjusted EBITDA: 50% weighting
    • Payout Structure:
      • Threshold: Payout of 50% of the target if met
      • Target: Set higher than the Company’s financial guidance
      • Maximum: Cap at 200% of the target annual incentive opportunity
    • Target Annual Incentive Opportunity: 60% of base salary for Stephen L. Silvestro
    • Vesting & Payment: Paid annually after the fiscal year; no vesting schedule applies
    • Evaluation Period: Fiscal 2024

    Annual Incentive Awards

    • Performance Metrics:
      • Revenue: 50% weight
      • Adjusted EBITDA: 50% weight
    • Payout Details:
      • Threshold Level: No payout if not met
      • Payout at Threshold: 50% of target
      • Maximum Award Level: 200% of the target incentive opportunity
    • Target Award for Stephen L. Silvestro: 60% of base salary
    • Additional Notes:
      • Exact performance achievement levels (threshold, target, and maximum) are not numerically specified in the documents

    This summarizes the performance-based compensation details provided for fiscal 2024.